What are we learning about the efficacy and safety of ultra-long-acting insulins such as degludec and U300 glargine?

What are we learning about the efficacy and safety of ultra-long-acting insulins such as degludec and U300 glargine?

What are we learning about the efficacy and safety of ultra-long-acting insulins such as degludec and U300 glargine?


Created by

CMEducation Resources IQ&A Interactive Intelligence Zone

Presenter

Robert Henry, MD

Robert Henry, MD

Chief, Center for Metabolic Research
Chief, Section of Endocrinology, Metabolism & Diabetes
Veterans Affairs Healthcare System
Professor of Medicine‚ Department of Medicine
Division of Endocrinology and Metabolism
University of California‚ San Diego